Sort by

Send to

Choose Destination

Links from PubMed

Items: 5


Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?

Xavier FD, Hoff PMG, Braghiroli MI, Paterlini ACCR, Souza KT, Faria LDBB, Ferreira FSB, Machado KK, Fernandes GDS.

J Glob Oncol. 2016 Jun 22;3(1):15-22. doi: 10.1200/JGO.2015.002527. eCollection 2017 Feb.


Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.

Zhao Y, Zhang D, Wang S, Tao L, Wang A, Chen W, Zhu Z, Zheng S, Gao X, Lu Y.

PLoS One. 2013;8(2):e56557. doi: 10.1371/journal.pone.0056557. Epub 2013 Feb 21.


Do circulating tumor cells play a role in coagulation and thrombosis?

Tormoen GW, Haley KM, Levine RL, McCarty OJ.

Front Oncol. 2012 Sep 10;2:115. doi: 10.3389/fonc.2012.00115. eCollection 2012.


Development of coagulation factor probes for the identification of procoagulant circulating tumor cells.

Tormoen GW, Cianchetti FA, Bock PE, McCarty OJ.

Front Oncol. 2012 Sep 6;2:110. doi: 10.3389/fonc.2012.00110. eCollection 2012.


The role of carrier number on the procoagulant activity of tissue factor in blood and plasma.

Tormoen GW, Rugonyi S, Gruber A, McCarty OJ.

Phys Biol. 2011 Dec;8(6):066005. doi: 10.1088/1478-3975/8/6/066005. Epub 2011 Nov 2.

Supplemental Content

Support Center